1h Free Analyst Time
The cardiac restoration systems market is forecasted to grow by USD 206.9 million during 2024-2029, accelerating at a CAGR of 5.8% during the forecast period. The report on the cardiac restoration systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising healthcare expenditure, rising prevalence of cvds, and growing medical tourism in emerging economies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The cardiac restoration systems market is segmented as below:
By End-user
- Hospitals
- ASCs
- Others
By Product
- Mitral valve restoration systems
- Left ventricular restoration systems
By Application
- Heart Failure
- Surgical ventricular restoration
- Percutaneous ventricular restoration
- Cardiac arrhythmias
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the cardiac restoration systems market covers the following areas:
- Cardiac Restoration Systems Market sizing
- Cardiac Restoration Systems Market forecast
- Cardiac Restoration Systems Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Market Segmentation by Product
10 Market Segmentation by Application
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global cardiac restoration systems market: Abbott Laboratories, AFFLUENT MEDICAL SA, Ancora Heart Inc., Artivion Inc., Baxter Regional Medical Center, BioVentrix Inc., Boston Scientific Corp., Edwards Lifesciences Corp., GE Healthcare Technologies Inc., Halma Plc, Lepu Medical Technology Beijing Co. Ltd., LivaNova PLC, Medtronic Plc, NeoChord Inc., OMRON Corp., Syntach AB, TECHNOGYM S.p.A, and Xeltis AG.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is development of mitral valve restoration systems with tissue engineering approach."
According to the report, one of the major drivers for this market is the rising healthcare expenditure.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AFFLUENT MEDICAL SA
- Ancora Heart Inc.
- Artivion Inc.
- Baxter Regional Medical Center
- BioVentrix Inc.
- Boston Scientific Corp.
- Edwards Lifesciences Corp.
- GE Healthcare Technologies Inc.
- Halma Plc
- Lepu Medical Technology Beijing Co. Ltd.
- LivaNova PLC
- Medtronic Plc
- NeoChord Inc.
- OMRON Corp.
- Syntach AB
- TECHNOGYM S.p.A
- Xeltis AG
